NCT02027233View on ClinicalTrials.gov

Clinical Trial to Assess the Influenza Vaccination of the Hospitalized Adults

NACompletedINTERVENTIONAL
Enrollment

6,173

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Severe Acute Respiratory Infection
Interventions
OTHER

nasopharyngeal sample

The nasopharyngeal sample will be used to find the types and subtypes of influenza virus and other respiratory viruses (VRS, SARS-CoV-2 and others).

Trial Locations (1)

75654

Institut National de la Santé Et de la Recherche Médicale, Paris

All Listed Sponsors
lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

NCT02027233 - Clinical Trial to Assess the Influenza Vaccination of the Hospitalized Adults | Biotech Hunter | Biotech Hunter